Σύγκριση μεθόδων

	Ανάλυση Κόστους-Αποτελεσματικότητας (CEA)	Ανάλυση Κόστους-Οφέλους (ΑΚΟ)
Πεδίο	Οικονομικά της Υγείας	Οικονομικά της Υγείας
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	1984	1970s
Δημιουργός	Drummond & Stoddart (Health Economics Research Group, McMaster University)	Boardman, Greenberg, and colleagues (welfare economics)
Τύπος	Method	Method
Θεμελιώδης πηγή	Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-Effectiveness in Health and Medicine. New York: Oxford University Press.	Boardman, A. E., Greenberg, D. H., Vining, A. R., & Weimer, D. L. (2018). Cost-Benefit Analysis: Concepts and Practice (5th ed.). Cambridge: Cambridge University Press.
Εναλλακτικές ονομασίες	CEA, ICER, Incremental Cost-Effectiveness Ratio	CBA, economic appraisal, benefit-cost ratio
Συναφείς	5	5
Σύνοψη	Cost-effectiveness analysis compares the incremental cost per unit of health benefit gained by one intervention relative to a comparator (standard care or best alternative). Developed rigorously in the 1980s by Drummond, Stoddart, and colleagues, CEA is now the standard framework for technology appraisal globally. NICE, HAS, CADTH, and other health technology assessment bodies use CEA to decide which treatments warrant public funding and at what price.	Cost-benefit analysis compares the total monetary value of benefits produced by a program against its total monetary costs, reporting net present value (NPV) or benefit-cost ratio (BCR). Rooted in welfare economics and used extensively in public policy (transportation, environmental, education, health), CBA answers the question: 'Is this program worth doing from a societal perspective?' Unlike cost-effectiveness analysis, CBA monetizes both costs and benefits, enabling comparison across disparate program types.